Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORBEX: Broncho-Vaxom for Prevention of Wheezing Lower Respiratory Tract Illness
NCT02148796Phase 2Completed
- Sponsor
- University of Arizona
- Start
- Jan 2017
- Primary completion
- Jan 2026
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Broncho-Vaxom (BV) with Placebo (2 arms). Primary endpoint: Time to the occurrence of the first WLRI episode in the observation period. Started Jan 2017; status: completed.
02
Drugs
OM-85
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02148796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02148796.